Steven Galson Quotations

There are dangers to consumers who purchase diet pills that contain drugs of unknown origin and quality. These products are not approved by the FDA and if people experience side effects, it is difficult to trace problems and for physicians to treat them.

Until today, patients with diabetes who need insulin to manage their disease has only one way to treat their condition.

This product has the potential to improve the quality of life for millions of Americans.

will lead to greater improvements in regulatory and drug development science and in how we evaluate and ensure the safety and efficacy of the products we regulate.

Today's approval is a major step forward in making breakthrough treatments available for patients with rare and difficult to treat forms of cancer.

We consider this approval an important advance in the treatment of head and neck cancer because it has been shown to help some patients live longer. Patients need as many effective treatment options as possible.

Doug's medical, regulatory and leadership skills make him an outstanding addition to CDER's senior management team and I am honored that he has agreed to continue as my deputy. Doug has brought invaluable leadership and support to me and others in the Agency and I'm confident that he will continue to do an outstanding job working to protect and advance public health.

FDA will be immediately notified and will take appropriate regulatory action if any serious safety concerns are identified,

FDA's action today is another example of the agency acting swiftly to alert the public to significant drug safety information needed to use a drug in a safe manner,

This approval is a welcome addition to the available defenses against the flu. This new use offers the medical community another option to prevent and control influenza A and B.

This is a very highly innovative product that will improve the quality of life for millions of Americans with diabetes.

The FDA's action today is another example of the agency acting swiftly to alert the public to significant drug safety information needed to use a drug in a safe manner.

The FDA is committed to sharing emerging drug information with the public and we believe it is important to share with health care providers and patients the latest serious reports of infection associated with this drug that we have received,